{"url_path":"/sec/indp/8-k/2026-06-24/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1857044/0001493152-26-029918-index.html","accession_number":"0001493152-26-029918","cik":"0001857044","ticker":"INDP","issuer_name":"Indaptus Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1857044/0001493152-26-029918-index.html","primary_entity_key":"0001857044","primary_entity_name":"Indaptus Therapeutics, Inc."},"word_count":82,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits.\n\n \n\n**Exhibit No.**\n \n**Description**\n\n10.1\n \n[Form of Stock Purchase Agreement, dated June 17, 2026](ex10-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the\nInline XBRL document)\n\n** **\n\n \n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDate:\nJune 24, 2026\n\n \n\n \n**INDAPTUS\nTHERAPEUTICS, INC.**\n\n \n \n \n\n \nBy:\n*/s/\nJunyi Dai*\n\n \nName:\nJunyi Dai\n\n \nTitle:\nChief Executive Officer"}